Fundz

Who to call at Sorriso Pharmaceuticals, and when

Fundz watches for the moments Sorriso Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Sorriso Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sorriso Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sorriso Pharmaceuticals. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchSorriso Pharmaceuticals Announces Positive Phase 1b Results for SOR102 to Treat Ulcerative Colitis.

Dec 19, 2024
Salt Lake CityBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Product Description

Sorriso Pharmaceuticals reported positive Phase 1b clinical trial results for SOR102, an oral biologic targeting immune-mediated disease, showing favorable safety and efficacy in patients with ulcerative colitis. The company plans to advance SOR102 into Phase 2 development following these promising trial outcomes.

Company Information

Company

Sorriso Pharmaceuticals

Location

Salt Lake City, Utah, United States

About

Sorriso Pharmaceuticals is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment of immune-mediated diseases, including ulcerative colitis and Crohn’s disease. They are developing novel orally dosed antibodies that target critical pathways in conditions like inflammatory bowel disease. Their innovative approach aims to deliver effective therapies with minimal systemic exposure. Sorriso is committed to transforming patient care in autoimmune therapeutics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sorriso Pharmaceuticals ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Mike hidden

hidden

Kevin hidden

hidden

Susan hidden

hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Sorriso Pharmaceuticals's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Sorriso Pharmaceuticals shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.